In brief

Oncoclínicas won support from 61.6% of creditors.

It can now seek approval of the plan.

What we know

04
  1. Verified fact · material

    Oncoclínicas reported support from creditors holding 61.6% of about R$ 5.7 billion in plan claims.

    Support.

    Sources[01][02]
  2. Verified fact · material

    With that support, the company reached the quorum needed to seek court approval of the plan.

    Quorum.

    Sources[01][02]
  3. Verified fact

    According to Times Brasil, support stood at 29.79% the day before.

    Progress.

    Sources[02]
  4. Verified fact

    According to Times Brasil, a majority does not equal court approval.

    Caveat.

    Sources[02]

Transmission to assets

Market read-through

The support is the company statement and still depends on the court to take effect.

Portfolio impact

01
ONCO3positive

Quorum reduces bankruptcy risk.

Court challenge.

What would change the view: Approval.

direct20% confidence

Direction is an explanatory hypothesis, not a forecast or recommendation.

Next signals

What to watch

  • Approval request
  • Court notice

Limits of the reporting

What remains uncertain

  • The plan has not been approved yet.

Full sources

02